Literature DB >> 16996713

Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro.

Daniel J Loegering1, James R Drake, Jeffrey A Banas, Tamara L McNealy, Debbie G Mc Arthur, Laura M Webster, Michelle R Lennartz.   

Abstract

The virulence of Francisella tularensis LVS is determined in part by its ability to invade and replicate within macrophages and stimulate the production of inflammatory cytokines. The present study determined the effects of growing F. tularensis in macrophages on its ability to stimulate cytokine secretion by macrophages. F. tularensis grown in Mueller-Hinton broth (FtB) stimulated the secretion of large amounts of TNF-alpha, IL-12p40, IL-6 and MCP-1/CCL2 when incubated with macrophages overnight. In contrast, F. tularensis released from infected macrophages (FtMac) stimulated very little secretion of these cytokines by primary cultures of murine peritoneal macrophages, human monocytes or macrophage cell lines. Stimulation of nitric oxide production by FtMac was also less than that elicited by FtB. FtMac killed with gentamicin or paraformaldehyde also stimulated low levels of cytokine secretion. FtMac recovered the ability to stimulate cytokine secretion after overnight culture in broth. Infection of macrophages with FtMac inhibited the cytokine response to subsequent stimulation with LPS from Escherichia coli but did not affect Fcgamma receptor-mediated phagocytosis. FtMac were ingested by macrophages at about half the rate of FtB, however, this did not account for the lower cytokine secretion. FtMac and FtB replicated at similar rates within macrophages. Finally, Mice infected with FtMac had a higher mortality rate than those infected with FtB. These results reveal that growth in macrophages causes a reversible phenotypic change in F. tularensis that is associated with decreased stimulation of cytokine secretion, inhibition of LPS-stimulated secretion of inflammatory cytokines by macrophages and increased lethality in mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996713      PMCID: PMC1950693          DOI: 10.1016/j.micpath.2006.07.007

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  27 in total

1.  Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity.

Authors:  C M Bosio; K L Elkins
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

Review 2.  Interplay between mycobacteria and host signalling pathways.

Authors:  Anil Koul; Thomas Herget; Bert Klebl; Axel Ullrich
Journal:  Nat Rev Microbiol       Date:  2004-03       Impact factor: 60.633

3.  Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS.

Authors:  J Wayne Conlan; Rhonda KuoLee; Hua Shen; Ann Webb
Journal:  Microb Pathog       Date:  2002-03       Impact factor: 3.738

4.  In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70.

Authors:  Karen L Elkins; Allison Cooper; Susan M Colombini; Siobhán C Cowley; Tara L Kieffer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  The requirement for gamma interferon in resistance of mice to experimental tularemia.

Authors:  L S Anthony; E Ghadirian; F P Nestel; P A Kongshavn
Journal:  Microb Pathog       Date:  1989-12       Impact factor: 3.738

Review 6.  Inducible nitric oxide synthase and control of intracellular bacterial pathogens.

Authors:  Dipshikha Chakravortty; Michael Hensel
Journal:  Microbes Infect       Date:  2003-06       Impact factor: 2.700

7.  Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages.

Authors:  Max Telepnev; Igor Golovliov; Thomas Grundström; Arne Tärnvik; Anders Sjöstedt
Journal:  Cell Microbiol       Date:  2003-01       Impact factor: 3.715

8.  Live vaccine strain of Francisella tularensis: infection and immunity in mice.

Authors:  A H Fortier; M V Slayter; R Ziemba; M S Meltzer; C A Nacy
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

Review 9.  Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain.

Authors:  Karen L Elkins; Siobhán C Cowley; Catharine M Bosio
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

10.  Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  23 in total

1.  Activities of daptomycin and comparative antimicrobials, singly and in combination, against extracellular and intracellular Staphylococcus aureus and its stable small-colony variant in human monocyte-derived macrophages and in broth.

Authors:  Aldona L Baltch; William J Ritz; Lawrence H Bopp; Phyllis Michelsen; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

2.  Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia.

Authors:  Sivakumar Periasamy; Anju Singh; Bikash Sahay; Tabassum Rahman; Paul J Feustel; Giang H Pham; Edmund J Gosselin; Timothy J Sellati
Journal:  J Leukoc Biol       Date:  2011-07-01       Impact factor: 4.962

3.  A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.

Authors:  Brian C Russo; Joseph Horzempa; Dawn M O'Dee; Deanna M Schmitt; Matthew J Brown; Paul E Carlson; Ramnik J Xavier; Gerard J Nau
Journal:  Infect Immun       Date:  2011-06-13       Impact factor: 3.441

4.  Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor β1.

Authors:  Samantha R Slight; Yinyao Lin; Michelle Messmer; Shabaana A Khader
Journal:  Cytokine       Date:  2011-06-12       Impact factor: 3.861

5.  Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.

Authors:  Michael D Valentino; Zachary J Maben; Lucinda L Hensley; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

6.  Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.

Authors:  Kari Ann Shirey; Leah E Cole; Achsah D Keegan; Stefanie N Vogel
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Modulation of virulence factors in Francisella tularensis determines human macrophage responses.

Authors:  Paul E Carlson; James A Carroll; Dawn M O'Dee; Gerard J Nau
Journal:  Microb Pathog       Date:  2007-02-15       Impact factor: 3.738

8.  Francisella gains a survival advantage within mononuclear phagocytes by suppressing the host IFNgamma response.

Authors:  Kishore V L Parsa; Jonathan P Butchar; Murugesan V S Rajaram; Thomas J Cremer; John S Gunn; Larry S Schlesinger; Susheela Tridandapani
Journal:  Mol Immunol       Date:  2008-06-02       Impact factor: 4.407

9.  Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis.

Authors:  Manish Mahawar; Girish S Kirimanjeswara; Dennis W Metzger; Chandra Shekhar Bakshi
Journal:  J Bacteriol       Date:  2009-06-05       Impact factor: 3.490

10.  Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.

Authors:  Karsten R O Hazlett; Seth D Caldon; Debbie G McArthur; Kerry A Cirillo; Girish S Kirimanjeswara; Micheal L Magguilli; Meenakshi Malik; Aaloki Shah; Scott Broderick; Igor Golovliov; Dennis W Metzger; Krishna Rajan; Timothy J Sellati; Daniel J Loegering
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.